Finally, since we have observed that spironolactone treatment blocked the aldosterone-mediated upregulation of GRK2 in myocytes (Fig. 2e), we investigated whether MR-antagonist-treated human HF patients had altered GRK2 levels in peripheral lymphocytes. This evidence concerns the gene NR3C2 and hydrops fetalis.